Source:http://linkedlifedata.com/resource/pubmed/id/21079332
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2010-11-16
|
pubmed:abstractText |
CD4+/CD56+ hematodermic neoplasm, formerly known as blastic NK cell lymphoma, is a rare and aggressive neoplasm with a high incidence of cutaneous involvement, risk of leukemic dissemination and poor prognosis. The characteristic features are expression of the T helper inducer cell marker CD4 and the NK-cell marker CD56 in the absence of other T cell or NKcell specific markers. Because of the rarity of this disease, we describe a 48 year old woman suffering from CD4+/CD56+ hematodermic neoplasm on her cheek without leukemic infiltration.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0973-3922
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
76
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
723
|
pubmed:meshHeading |
pubmed-meshheading:21079332-Adult,
pubmed-meshheading:21079332-Antigens, CD4,
pubmed-meshheading:21079332-Antigens, CD56,
pubmed-meshheading:21079332-CD4-Positive T-Lymphocytes,
pubmed-meshheading:21079332-Female,
pubmed-meshheading:21079332-Humans,
pubmed-meshheading:21079332-Lymphoma, T-Cell, Cutaneous,
pubmed-meshheading:21079332-Skin Neoplasms
|
pubmed:articleTitle |
Cutaneous CD4+/CD56+ hematodermic neoplasm.
|
pubmed:affiliation |
Department of Dermatology, Goztepe Training and Resach Hospital, Istanbul, Turkey. ilkin.dr@gmail.com
|
pubmed:publicationType |
Journal Article,
Case Reports
|